相关实验视频

Updated: May 13, 2025

Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia

Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia

Published on: December 19, 2020

探索COVID-19的临床和成像差异:IFITM3 rs12252多态的观察方法

Adriana Mitrea^1,2, Anca-Florentina Mitroi^3,4, Cristian Opariuc-Dan⁵

¹Doctoral School of Medicine, "Ovidius" University of Constanta, Constanta, Romania.

International journal of general medicine

|April 15, 2025

概括

干扰素诱导的跨膜蛋白3 (IFITM3) rs12252多态,特别是G等位基因,与严重的COVID-19相关. 在严重病例中观察到较高的炎症标志物,这表明它在疾病进展中的作用.

科学领域:

遗传学和传染病的研究
分子生物学和免疫学分子生物学和免疫学

背景情况:

COVID-19的严重程度表现出显著的个体变化.
影响COVID-19结果的因素正在接受广泛调查.
干扰素诱导的跨膜蛋白3 (IFITM3) rs12252多态性是一种潜在的影响因素.

研究的目的:

调查IFITM3 rs12252多态体在特定人群中COVID-19严重性中的作用.
为了比较轻度和严重的COVID-19病例之间的炎症标志物.

主要方法:

在51名COVID-19患者 (31名严重,20名轻度) 上进行了一项观察性研究.
这项研究分析了IFITM3 rs12252多态性与COVID-19严重程度相关.
评估了炎症标志物 (ESR,CRP,纤维素,LDH,D-二次体) 和CT扫描得分.

主要成果:

IFITM3 rs12252的AG基因型存在于16.1%的严重COVID-19患者中.
与轻度病例相比,严重的COVID-19病例显示ESR,CRP,纤维素,LDH和D-二次体水平显著升高.
在IFITM3 rs12252的G等位基因,炎症标志物升高,CT得分和COVID-19严重程度之间发现了相关性.

结论:

IFITM3 rs12252多态的G基因与COVID-19严重程度的增加有关.
炎症标志物和CT扫描得分的升高与这种多态性和疾病严重程度有关.
这表明IFITM3 rs12252可能是预测严重COVID-19结果的遗传标记.

关键词:

在 COVID-19 疫情中,在IFITM3蛋白质中,IFITM3是一种蛋白质.基因型基因型基因型炎症标志物的炎症标志物

更多相关视频

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Published on: April 4, 2018

A Method to Study the C924T Polymorphism of the Thromboxane A2 Receptor Gene

A Method to Study the C924T Polymorphism of the Thromboxane A2 Receptor Gene

Published on: April 1, 2019

相关概念视频

Single Nucleotide Polymorphisms-SNPs

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...